Progestin Therapy of Endometrial, Breast and Ovarian Carcinoma

Progestational Agents in the Treatment of Carcinoma of the Endometrium

1961 • 255 citations

Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implications

1981 • 190 citations

Clinical Correlates of Estrogen- and Progesterone-Binding Proteins in Human Endometrial Adenocarcinoma

1980 • 154 citations

TREATMENT OF ADENOCARCINOMA OF THE ENDOMETRIUM

1975 • 142 citations

Epidemiology of cancer of the ovary

1969 • 141 citations

Hormone dependency of breast cancer

1981 • 141 citations

Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy

1979 • 134 citations

INDUCTIOS OF OVULATIOK WITH CLOAIIPHESE CITRATE (CLOAIID)

1965 • 124 citations

Gestagens and endometrial carcinoma

1976 • 106 citations

Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration

1979 • 104 citations

Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.

1980 • 103 citations

Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer

1974 • 103 citations

Do Estrogen and Progesterone Receptors (E₂R and PR) in Metastasizing Endometrial Cancers Predict the Response to Gestagen Therapy?

1980 • 99 citations

Epithelial Carcinoma of the Ovary: Current Strategies

1981 • 97 citations

Medroxyprogesterone acetate (depo-provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma

1980 • 89 citations

Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetate

1965 • 87 citations

Treatment of Breast Cancer with Medroxyprogesterone Acetate

1968 • 81 citations

Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer

1979 • 70 citations

Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate

1978 • 70 citations

Progestin therapy in advanced breast cancer: Megestrol acetate—an evaluation of 160 treated cases

1980 • 70 citations

Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor‐like lesions of human ovary

1980 • 70 citations

High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response Evaluation

1978 • 69 citations

Progesterone in the Treatment of Advanced Malignant Tumours of Breast, Ovary and Uterus

1962 • 68 citations

A Study of Estrogen and Progesterone Cytosol Receptor Concentration in Benign and Malignant Ovarian Tumors and A Review of Malignant Ovarian Tumors Treated with Medroxy‐Progesterone Acetate

1981 • 66 citations

Chemotherapy of gynecologic cancer

1984 • 66 citations

Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels

1980 • 65 citations

Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma

1981 • 64 citations

Advanced ovarian carcinoma: Response to antiestrogen therapy

1981 • 63 citations

Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen

1982 • 63 citations

The role of progesterone in human endometrial cancer.

1965 • 62 citations

Hydroxyprogesterone caproate therapy in advanced endometrial cancer

1971 • 59 citations

Clinical outcome in endometrial cancer.

1982 • 57 citations

Progestogen treatment of recurrent endometrial carcinoma

1971 • 53 citations

Treatment of advanced endomeprtrial adenocarcinoma with a combined cytotoxic therapy. Predictive value of cytosol estrogen and progestin receptor levels

1980 • 52 citations

High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy

1979 • 52 citations

PROGESTOGEN THERAPY FOR OVARIAN CARCINOMA

1972 • 44 citations

Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.

1977 • 44 citations

A clinical trial of megestrol acetate in advanced breast cancer

1974 • 42 citations

Use of progestational agents in endometrial adenocarcinoma.

1974 • 41 citations

Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma.

1977 • 38 citations

Progestins in the treatment of patients with endometrial adenocarcinoma

1966 • 38 citations

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group

1969 • 37 citations

The use of megestrol acetate in the treatment of advanced malignant lesions of the endometrium

1973 • 36 citations

Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.

1977 • 36 citations

Epidemiology of Cancer of the Endometrium

1982 • 36 citations

An overview of hormone-associated cancers.

1978 • 35 citations

Adjuvant Progesterone Therapy for Stage I Endometrial Carcinoma

1978 • 35 citations

EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE-17-n-CAPROATE ON VARIOUS PELVIC MALIGNANCIES

1964 • 34 citations

High Dose Medroxyprogesterone-Acetate Treatment in Advanced Mammary Carcinoma: A Phase II Investigation

1978 • 33 citations

Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate

1981 • 30 citations

Treatment of Advanced Breast Cancer with Progestins: A review

1981 • 29 citations

Management of Advanced Ovarian Carcinoma

1966 • 29 citations

Progestin therapy for advanced ovarian cancer: a phase II Eastern Cooperative Oncology Group trial.

1981 • 27 citations

Megestrol acetate in the management of advanced endometrial carcinoma.

1973 • 25 citations

The 1946 Year Book of Obstetrics and Gynecology

1947 • 24 citations

Medroxyprogesterone Acetate (MPA) Plasma Levels After Oral and Intramuscular Administration in A Long‐Term Study

1981 • 23 citations

Hormonal and Cytotoxic Chemotherapy for Endometrial Carcinoma: Steroid receptors in the selection of appropriate therapy

1981 • 21 citations

6 Alpha‐Methyl‐17 Alpha‐Hydroxyprogesterone Acetate1 as a Chemotherapeutic Agent in Adenocarcinoma of the Uterus

1966 • 21 citations

Progestogen treatment of recurrent carcinoma of the endometrium

1966 • 21 citations

Hormone receptors in endometrial cancer

1981 • 19 citations

Norethisterone acetate (SH420) in advanced breast cancer

1973 • 19 citations

Symposium on Steroids in Experimental and Clinical Practice

1952 • 17 citations

6-Dehydro-6,17 alpha-dimethylprogesterone (NSC-123018) for the treatment of metastatic and recurrent ovarian carcinoma.

1973 • 17 citations

Chemotherapeutic Treatment of Endometrial Carcinoma

1982 • 16 citations

Chemotherapy in Gynecologic Cancer

1978 • 14 citations

Norethisterone acetate in the treatment of advanced breast cancer

1976 • 14 citations

Tamoxifen and Aminoglutethimide in the Management of Patients With Advanced Endometrial Carcinoma Not Responsive to Medroxyprogesterone

1981 • 14 citations

THE TREATMENT OF ADVANCED CYSTADENOCARCINOMA OF THE OVARY WITH GESTRONOL AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE

1979 • 14 citations

The effects of clomiphene citrate on the endometrium

1965 • 12 citations

Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.

1976 • 12 citations

The use of progestins in obstetrics and gynecology

1969 • 11 citations

PROGESTAGENS AND ADVANCED BREAST CANCER

1971 • 10 citations

Current status of therapeutic modalities for treatment of gynecologic malignancies with emphasis on chemotherapy

1981 • 10 citations

Die hochdosierte Gestagenbehandlung in der Therapie des fortgeschrittenen Mammakarzinoms

1979 • 9 citations

Treatment of advanced endometrial carcinoma with a progestational agent

1969 • 9 citations

Systemic Therapy of Metastatic Breast Cancer: A Review of the Current Trends

1982 • 8 citations

Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.

1980 • 8 citations

Locating the placenta.

1967 • 7 citations

Endometrial Carcinoma Insensitive to Progestin and Cytotoxic Chemotherapy May Respond to Tamoxifen

1981 • 6 citations

Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.

1980 • 5 citations

Deleted Work

1955 • 0 citations